Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWGalgravin is a lignan that has been found in N. megapotamica and has diverse biological activities.1,2,3,4 It inhibits the binding of platelet-activating factor (PAF) to isolated rabbit platelet plasma membranes (IC50 = 4.5 µM).1 Galgravin (3-100 µM) inhibits osteoclast formation induced by RANKL and macrophage colony-stimulating factor (M-CSF) in mouse bone marrow-derived macrophages.2 It protects against cytotoxicity induced by human amyloid-β (25-35) (Aβ (25-35); Item No. 24155) in primary rat hippocampal neurons when used at a concentration of 10 µM.3 Galgravin (20 mg/kg) reduces acetic acid-induced abdominal constrictions in mice and carrageenan-induced paw edema in rats.4
WARNING This product is not for human or veterinary use.
1. Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists. J. Med. Chem. 29(10), 1917-1921 (1986).
2. Effects of veraguensin and galgravin on osteoclast differentiation and function. Cytotechnology 64(3), 315-322 (2012).
3. Neuroprotective effects of 2,5-
4. Evaluation of analgesic and anti-